Skip to main content
SpringerLink
Log in

Chronopharmacokinetics

Current Status

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Absorption, distribution, metabolism and elimination are influenced by many different physiological functions of the body which may vary with time of day. Thus, the pharmacokinetic parameters characterising these different steps, conventionally considered to be constant in time, depend on the moment of drug administration. Time of day has to be regarded as an additional variable influencing the kinetics of a drug.

Chronokinetic studies have been reported for many drugs in an attempt to explain chronopharmacodynamic phenomena and demonstrate that the time of administration is a possible factor of variation in the kinetics of a drug. In this paper this is illustrated with the chronopharmacokinetics of cardiovascular and nonsteroidal anti-inflammatory drugs.

Time-dependent changes in kinetics may proceed from circadian variations at each step, e.g. absorption, distribution, metabolism and elimination. Thus, circadian variations in gastric acid secretion and pH, motility, gastric emptying time, gastrointestinal blood flow, drug protein binding, liver enzyme activity and/or hepatic blood flow, glomerular filtration, renal blood flow, urinary pH and tubular resorption may play a role in such kinetic variations.

New tools, such as new formulation procedures or pumps with constant or programmable delivery rates, now make it possible to deliver a drug at a definite time, or during a definite span of time and at a controlled rate in chronokinetic studies.

Microdialysis would be of particular interest in chronopharmacological and chronokinetics studies, but, surprisingly, very few chronobiological studies have been conducted using this technique. With regard to new models and concepts in chronokinetics, pharmacokinetic-pharmacodynamic modelling may be useful, and modelling of the chronopharmacological patterns of drug response and kinetics have been attempted by some authors.

Drug chronopharmacokinetic knowledge may be clinically relevant as it may have implications for drug prescription by modulating the distribution of the total daily dose along the 24-hour scale. However, it seems reasonable to consider chronopharmacokinetic studies in specific cases related to patients, illness or the drug itself. When conducting a chronokinetic study it is not only necessary to take into account differences in the time of administration but to also have strict control of all other possible variables which are known to influence pharmacokinetic processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reinberg A. Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol 1992; 32: 51–66.

    Article  PubMed  CAS  Google Scholar 

  2. Reinberg A, Smolensky M. Circadian changes of drug disposition in man. Clin Pharmacokinet 1982; 7: 401–20.

    Article  PubMed  CAS  Google Scholar 

  3. Bruguerolle B. Recent data in chronopharmacokinetics. Pathol Biol 1987; 35: 925–34.

    PubMed  CAS  Google Scholar 

  4. Levi F, Bruguerolle B, Hecquet B. Mechanisms and perspectives in clinical chronopharmacokinetics. Therapie 1989; 44: 313–21.

    PubMed  CAS  Google Scholar 

  5. Labrecque G, Belanger P. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 1991; 52: 95–107.

    Article  PubMed  CAS  Google Scholar 

  6. Bruguerolle B, Lemmer B. Recent advances in chronopharmacokinetics: methodological problems. Life Sci 1993; 52: 1809–24.

    Article  PubMed  CAS  Google Scholar 

  7. Lemmer B, Bruguerolle B. Chronopharmacokinetics: are they clinically relevant? Clin Pharmacokinet 1994; 26: 419–27.

    Article  PubMed  CAS  Google Scholar 

  8. Bruguerolle B, Desnuelle C, Jadot G, et al. Chronopharmacocinétique de l’indométhacine a effet prolongé en pathologie rhumatismale. Rev Int Rhum 1983; 13: 263–7.

    Google Scholar 

  9. Bruguerolle B, Grignon S. Chronopharmacologie. Pathol Biol 1996; 44: 547–54.

    PubMed  CAS  Google Scholar 

  10. Bruguerolle B. Chronopharmacology. In: Touitou Y, Haus E, editors. Biological rhythms in clinical and laboratory medicine. Paris: Springer-Verlag, 1992: 114–37.

    Chapter  Google Scholar 

  11. Belanger P, Bruguerolle B, Labrecque G. Rhythms in pharmacokinetics: absorption, distribution, metabolism and excretion. In: Redfern PH, Lemmer B, editors. Physiology and pharmacology of biological rhythms. Heidelberg: Springer-Verlag, 1997: 177–204.

    Google Scholar 

  12. Bruguerolle B. Chronopharmacokinetics aspects with special reference to cardiovascular drugs. In: Schmidt T, Engel B, Blumchen G, editors. Temporal variations of the cardiovascular system. Heidelberg: Springer-Verlag, 1992: 371–81.

    Google Scholar 

  13. Shiga T, Fujimura A, Tateishi T, et al. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects. Eur J Clin Pharmacol 1993; 44: 489–92.

    Article  PubMed  CAS  Google Scholar 

  14. Lemmer B, Portaluppi F. Chronopharmacology of cardiovascular diseases. In: Redfern PH, Lemmer B, editors. Physiology and pharmacology of biological rhythms. Heidelberg: Springer-Verlag, 1997: 251–98.

    Google Scholar 

  15. Demey C, Meineke I. Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA). Br J Clin Pharmacol 1992; 33: 179–82.

    Article  CAS  Google Scholar 

  16. Mustofa M, Suryawati S, Dwiprahasto I, et al. The relative bioavailability of diclofenac with respect of time of administration. Br J Clin Pharmacol 1991; 32: 246–7.

    Article  PubMed  CAS  Google Scholar 

  17. Clench J, Reinberg A, Dziewanowska Z, et al. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981; 20: 359–69.

    Article  PubMed  CAS  Google Scholar 

  18. Guissou P, Cuisinaud G, Llorca G, et al. Chronopharmacokinetic study of a prolonged release form of indomethacin. Eur J Clin Pharmacol 1983; 24: 667–70.

    Article  PubMed  CAS  Google Scholar 

  19. Bruguerolle B, Barbeau G, Belanger P, et al. Chronokinetics of indomethacin in elderly subjects. Annu Rev Chro-nopharmacol 1986; 3: 425–8.

    CAS  Google Scholar 

  20. Ollagnier M, Decousus H, Cherrah Y, et al. Circadian changes in the pharmacokinetics of oral ketoprofen. Clin Pharmacokinet 1987; 12: 367–78.

    Article  PubMed  CAS  Google Scholar 

  21. Reinberg A, Levi F, Touitou Y, et al. Clinical pharmacikinetic changes in a sustained release preparation of ketoprofen (SRK). Annu Rev Chronopharmacol 1986; 3: 317–20.

    CAS  Google Scholar 

  22. Decousus H, Ollagnier M, Cherrah Y, et al. Chronokinetics of ketoprofen infused intravenously at a constant rate. Annu Rev Chronopharmacol 1986; 3: 321–4.

    Google Scholar 

  23. Srinivasu P, Rambhau D, Rao R. Chronopharmacokinetics of ketorolac in healthy volunteers. Clin Drug Invest 1995; 10: 110–6.

    Article  CAS  Google Scholar 

  24. Fujimura A, Kajiyama H, Kumagai Y, et al. Chronopharmacokinetic studies of propanofen and procainamide. J Clin Pharmacol 1989; 29: 786–90.

    PubMed  CAS  Google Scholar 

  25. Markiewicz A, Semenowicz K. Time dependent change in the pharmacokinetics of aspirin. Int J Clin Pharmacol Biopharm 1979; 17: 409–11.

    PubMed  CAS  Google Scholar 

  26. Reinberg A, Clench J, Ghata J, et al. Rythmes circadiens des paramétres de l’excrétion urinaire du salycylate (chronopharmacocinétique) chez l’homme adulte sain. C R Acad Sci 1975; 280: 1697–700.

    CAS  Google Scholar 

  27. Couet W, Ingrand I, Millerioux L, et al. Etude chronopharmacocinétique du sulindac et de ses metabolites. Sem Hop Paris 1986; 62: 2677–82.

    CAS  Google Scholar 

  28. Ohdo S, Nakano S, Ogawa N. Circadian changes of valproate kinetics depending on meal conditions in humans. J Clin Pharmacol 1992; 32: 822–6.

    PubMed  CAS  Google Scholar 

  29. Ronfeld RA, Wilner KD, Baris BA, et al. Sertraline: chronopharmacokinetics and the effect of coadministration with food. Clin Pharmacokinet 1997; 32: 50–5.

    Article  PubMed  CAS  Google Scholar 

  30. Bruguerolle B, Giaufre E, Prat M. Temporal variations in transcutaneous passage of drugs: the example of lidocaine in children and in rats. Chronobiol Intern 1991; 8: 277–82.

    Article  CAS  Google Scholar 

  31. Bruguerolle B. Local anaesthetics. In: Redfern PH, Lemmer B, editors. Physiology and pharmacology of biological rhythms. Heidelberg: Springer-Verlag, 1997: 607–18.

    Google Scholar 

  32. Reinberg A, Soudant E, Koulbanis C, et al. Circadian dosing time dependency in the forearm skin penetration of methyl and hexyl nicotinate. Life Sci 1995; 57: 1507–13.

    Article  PubMed  CAS  Google Scholar 

  33. Ohdo S, Grass GM, Lee VH. Improving the ocular to systemic ratio of topical timolol by varying the dosing time. Invest Ophthalmol Vis Sci 1991; 32: 2790–8.

    PubMed  CAS  Google Scholar 

  34. Reinberg A, Schuller E, Deslanerie N, et al. Rythmes circadiens et circannuels des leucocytes, proteines totales, immunoglobulines A, G et M. Etude chez neuf adultes jeunes et sains. Nouv Presse Med 1977; 6: 3819–23.

    PubMed  CAS  Google Scholar 

  35. Bruguerolle B. Temporal variations in tissular and plasma protein binding of drugs with special references to their erythrocyte penetration as mechanisms involved in chronopharmacological effects. In: Vandendriessche T, Guisset JL, Petiau De Vries GM, et al., editors. Membranes and circadian rhythms. Heidelberg: Springer-Verlag, 1996: 159–67.

    Chapter  Google Scholar 

  36. Belanger PM. Chronobiological variation in the hepatic elimination of drugs and toxic chemical agents. Ann Rev Chronopharmacol 1988; 4: 1–46.

    CAS  Google Scholar 

  37. Feuers RJ, Scheving LE. Chronobiology of hepatic enzymes. Ann Rev Chronopharmacol 1988; 4: 209–54.

    CAS  Google Scholar 

  38. Belanger PM, Labrecque G. Temporal aspects of drug metabolism. In: Lemmer B, editor. Chronopharmacology: cellular and biochemical interactions. Basel: Marcel Dekker, 1991: 15–34.

    Google Scholar 

  39. Lemmer B, Nold G. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 1991; 32: 624–9.

    Article  Google Scholar 

  40. Shaw GL, Falk RT, Caporaso NE, et al. Effect of diurnal variation on debrisoquine metabolic phenotyping. J Nat Cancer Inst 1990; 82: 1573–5.

    Article  PubMed  CAS  Google Scholar 

  41. Cambar J, Cal JC, Tranchot J. Renal excretion: rhythms in physiology and pathology. In: Touitou Y, Haus E, editors. Biological rhythms in clinical and laboratory medecine. Paris: Springer-Verlag, 1992: 470–82.

    Chapter  Google Scholar 

  42. Reinberg A, Clench J, Ghata J, et al. Rythmes circadiens des parametres de l’excretion urinaire du salicylate (chronopharmacocinétique) chez l’homme adulte sain. C R Acad Sci (Paris) 1975; 280: 1697–700.

    CAS  Google Scholar 

  43. Dettli L, Spring P. Diurnal variations in the elimination rate of a sulfonamide in man. Helv Med Acta 1966; 4: 921–6.

    Google Scholar 

  44. Lemmer B, Scheidel B, Blume H, et al. Clinical chronopharmacology of oral sustained-release isosorbite-5-mononitrate in healthy subjects. Eur J Clin Pharmacol 1991; 40: 71–5.

    Article  PubMed  CAS  Google Scholar 

  45. Lemmer B, Nold G, Behne S, et al. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int 1991; 8: 485–94.

    Article  PubMed  CAS  Google Scholar 

  46. Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs: propranolol, organic nitrates and nifedipine. Ann N Y Acad Sci 1991; 618: 166–81.

    Article  PubMed  Google Scholar 

  47. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid inmetastatic colorectal cancer. Lancet 1997; 350: 681–6.

    Article  PubMed  CAS  Google Scholar 

  48. Levi F. Chronopharmacology of anticancer agents. In: Redfern PH, Lemmer B, editors. Physiology and pharmacology of biological rhythms. Heidelberg: Springer-Verlag, 1997: 299–331.

    Google Scholar 

  49. Bruguerolle B, Dupont M, Lebre P, et al. Bupivacaine chronokinetics in man after a peridural constant rate infusion. Annu Rev Chronopharmacol 1988; 5: 223–6.

    Google Scholar 

  50. Ando Y, Minami H, Sakai S, et al. Is there a circadian variation in plasma concentrations of etoposide given by prolonged continuous infusion? Cancer Chemother Pharmacol 1996; 37: 616–8.

    Article  PubMed  CAS  Google Scholar 

  51. Petit E, Milano G, Levi F, et al. Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five day continuous venous infusion at a constant rate in cancer patients. Cancer Res 1988; 48: 1676–9.

    PubMed  CAS  Google Scholar 

  52. Sanders SW, Bishop AL, Moore JG. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant infusion rate. Chronobiol Intern 1991; 8: 267–76.

    Article  CAS  Google Scholar 

  53. Philip-Joet F, Bruguerolle B, Lagier F, et al. Effects of a constant dose rate of terbutaline on circadian peak expiratory flow, heart rate and systolic arterial pressure in patients with asthma exacerbation. Respiration 1992; 59: 197–200.

    Article  PubMed  CAS  Google Scholar 

  54. Coulthard KP, Birkett DJ, Lines DR, et al. Bioavailability and diurnal variation and absorption of sustained release theophylline in asthmatic children. Eur J Clin Pharmacol 1983; 25: 667–72.

    Article  PubMed  CAS  Google Scholar 

  55. Uematsu T, Follath F, Voze S. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction. Eur J Clin Pharmacol 1986; 30: 309–12.

    Article  PubMed  CAS  Google Scholar 

  56. Focan C, Doalto L, Mazy V, et al. Vindésine en perfusion continue de 48 heures (suivie de cisplatine) dans le cancer pulmonaire avancé: données chronopharmacocinétiques et efficacité clinique. Bull Cancer 1989; 76: 909–12.

    PubMed  CAS  Google Scholar 

  57. Johansen MJ, Newman RA, Madden T. The use of microdialysis in pharmacokinetics and pharmacodynamics. Pharmacotherapy 1997; 17: 464–81.

    PubMed  CAS  Google Scholar 

  58. Bruguerolle B. General concepts and new trends in chronopharmacology. In: Touitou Y, editor. Biological clocks: mechanisms and applications. International Congress of Chronobiology; 1998 Sep 7–11; Paris. North Holland: Elsevier Pergamon, 1998: 437–43

    Google Scholar 

  59. Ungerstedt U. Microdialysis principles and applications for studies in animal and man. J Intern Med 1991; 230: 365–73.

    Article  PubMed  CAS  Google Scholar 

  60. Lehman JC, Jones TR, Mishra PK, et al. A novel microdialysis probe designed for clinical use: potential analytical and therapeutic applications. Acta Neurochir 1996; 67: 66–9.

    Google Scholar 

  61. Scheiner LB, Stanski DR, Vozehet S, et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358–71.

    Google Scholar 

  62. Aronson JK, Chappell MJ, Godfrey KR, et al. Modelling circadian variation in the pharmacokinetics of non-steroidal antiinflammatory drugs. Eur J Clin Pharmacol 1993; 45: 357–61.

    Article  PubMed  CAS  Google Scholar 

  63. Shappell SA, Kearns GL, Valentine JL, et al. Chronopharmacokinetics and chronopharmacodynamics of dextrometh-amphetamine in man. J Clin Pharmacol 1996; 36: 1051–63.

    Article  PubMed  CAS  Google Scholar 

  64. Lemmer B. Chronopharmacological aspects of PK/PD modelling. Int J Clin Pharmacol Ther 1997; 35: 458–64.

    PubMed  CAS  Google Scholar 

  65. Reinberg A, Levi F, Smolensky M, et al. Chronokinetics. In: Hansch C, editor. Comprehensive medicinal chemistry. Oxford: Pergamon Press, 1990: 279–96.

    Google Scholar 

  66. Hecquet B. Constant pharmacologic effect and chronopharmacology: theoretical aspects. Chronobiology Int 1986; 3: 149–54.

    Article  CAS  Google Scholar 

  67. Hecquet B, Sucche M. Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve. J Pharmacokinet Biopharm 1986; 14: 79–93.

    PubMed  CAS  Google Scholar 

  68. Hecquet B. Theoretical aspects of chronopharmacology. Annu Rev Chronopharmacol 1990; 6: 1–24.

    CAS  Google Scholar 

  69. Gries JM, Benowitz N, Verotta D. Chronopharmacokinetics of nicotine. Clin Pharmacol Ther 1996; 60: 385–95.

    Article  PubMed  CAS  Google Scholar 

  70. Langner B, Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 1988; 33: 619–24.

    Article  PubMed  CAS  Google Scholar 

  71. Lemmer B, Nold G, Behne S, et al. Chronopharmacology of oral nifedipine in healthy subjects and in hypertensive patients. Eur J Pharmacol 1990; 183: 521–26.

    Article  Google Scholar 

  72. Lemmer B. Implications of chronopharmacokinetics for drug delivery: antiasthmatics, H2-blockers and cardiovascular active drugs. Adv Drug Deliv Rev 1991; 6: 83–100.

    Article  CAS  Google Scholar 

  73. Bruguerolle B, Philip-Joet F, Parrel M, et al. Unequal twicedaily sustained release theophylline dosing in chronic obstructive pulmonary disease. Respiration 1992; 59: 197–200.

    Article  PubMed  Google Scholar 

  74. Bruguerolle B, Reinberg A, Levi F. Publicité médicale et chronopharmacologie. Biomed Pharmacother 1986; 40: 206–7.

    PubMed  CAS  Google Scholar 

  75. Bruguerolle B. Chronobiology for increasing drug sales: use, misuse and abuse. Biol Rhythms Res 1995; 26: 362.

    Google Scholar 

  76. Bruguerolle B, Arnaud C, Levi F, et al. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology. In: Baumann P, Eap CB, Müller WE, et al., editors. Alpha 1 acid glycoprotein: genetics, biochemistry, physiological functions and pharmacology. New York: Alan R Liss, 1989: 199–214.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine Marseilles, Medical and Clinical Pharmacology, 27 Bd Jean Moulin, F 13385, Marseilles Cedex 5, France

    Bernard Bruguerolle

Authors
  1. Bernard Bruguerolle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernard Bruguerolle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruguerolle, B. Chronopharmacokinetics. Clin Pharmacokinet 35, 83–94 (1998). https://doi.org/10.2165/00003088-199835020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199835020-00001

Keywords

Search

Navigation